Work

S1777 A Comparison of Adverse Events of Upadacitinib and Vedolizumab with Adalimumab in Ulcerative Colitis: Insights into Real-World Data From a Pharmacovigilance Database

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001134568.74864.52

Authors: Yash P. Ashara, Ruchir Paladiya, Madhav Changela, Bhavtosh Dedania

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417195685

Cites:

Cited by:

Related to: